A top scientific officer whose concerns about puberty blockers led to the pausing of a national trial has now been removed from involvement with it due to concerns about his “gender-critical” views.
Professor Jacob George was appointed as the first Chief Medical and Scientific Officer for the Medicines and Healthcare products Regulatory Agency (MHRA) late last year.
He subsequently raised concerns, according to The Sunday Times, for the safety of participants in a nationwide trial of puberty blockers that was set to begin earlier this year.
